140 related articles for article (PubMed ID: 36856845)
1. Untreated anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia progressing over 27 years.
Schegk E; Beiser I; Achtnichts L; Nedeltchev K; Bertschi M; Gschwind M
J Neurol; 2023 Jun; 270(6):3258-3260. PubMed ID: 36856845
[No Abstract] [Full Text] [Related]
2. Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis.
Jarius S; Komorowski L; Regula JU; Haas J; Brakopp S; Wildemann B
J Neurol; 2022 Oct; 269(10):5420-5430. PubMed ID: 35624318
[TBL] [Abstract][Full Text] [Related]
3. From dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.
Wallwitz U; Brock S; Schunck A; Wildemann B; Jarius S; Hoffmann F
J Neuroimmunol; 2017 Aug; 309():77-81. PubMed ID: 28601293
[TBL] [Abstract][Full Text] [Related]
4. Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.
Jarius S; Martínez-García P; Hernandez AL; Brase JC; Borowski K; Regula JU; Meinck HM; Stöcker W; Wildemann B; Wandinger KP
J Neuroinflammation; 2013 Jan; 10():7. PubMed ID: 23320754
[TBL] [Abstract][Full Text] [Related]
5. Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline.
Doss S; Nümann A; Ziegler A; Siebert E; Borowski K; Stöcker W; Prüss H; Wildemann B; Endres M; Jarius S
J Neuroimmunol; 2014 Feb; 267(1-2):102-4. PubMed ID: 24439423
[TBL] [Abstract][Full Text] [Related]
6. Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis.
Jarius S; Haas J; Wildemann B
J Neurol; 2023 Mar; 270(3):1776-1780. PubMed ID: 36333454
[No Abstract] [Full Text] [Related]
7. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
8. Psychotic syndrome associated with anti-Ca/ARHGAP26 and voltage-gated potassium channel antibodies.
Jarius S; Wildemann B; Stöcker W; Moser A; Wandinger KP
J Neuroimmunol; 2015 Sep; 286():79-82. PubMed ID: 26298328
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
Jarius S; Scharf M; Begemann N; Stöcker W; Probst C; Serysheva II; Nagel S; Graus F; Psimaras D; Wildemann B; Komorowski L
J Neuroinflammation; 2014 Dec; 11():206. PubMed ID: 25498830
[TBL] [Abstract][Full Text] [Related]
10. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.
Jarius S; Wandinger KP; Horn S; Heuer H; Wildemann B
J Neuroinflammation; 2010 Mar; 7():21. PubMed ID: 20226058
[TBL] [Abstract][Full Text] [Related]
11. Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment.
Bartels F; Prüss H; Finke C
Front Neurol; 2018; 9():656. PubMed ID: 30158896
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies.
Yoshikura N; Kimura A; Fukata M; Fukata Y; Yokoi N; Harada N; Hayashi Y; Inuzuka T; Shimohata T
J Neuroimmunol; 2018 Jun; 319():63-67. PubMed ID: 29685291
[TBL] [Abstract][Full Text] [Related]
13. Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody.
Shiihara T; Kato M; Konno A; Takahashi Y; Hayasaka K
Brain Dev; 2007 May; 29(4):254-6. PubMed ID: 17049194
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in childhood post-varicella acute cerebellar ataxia.
Adams C; Diadori P; Schoenroth L; Fritzler M
Can J Neurol Sci; 2000 Nov; 27(4):316-20. PubMed ID: 11097523
[TBL] [Abstract][Full Text] [Related]
15. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
Mitoma H; Nanri K
Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
Nanri K; Okita M; Takeguchi M; Taguchi T; Ishiko T; Saito H; Otsuka T; Mitoma H; Koizumi K
Intern Med; 2009; 48(10):783-90. PubMed ID: 19443972
[TBL] [Abstract][Full Text] [Related]
17. Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.
Mitoma H; Honnorat J; Yamaguchi K; Manto M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668612
[TBL] [Abstract][Full Text] [Related]
18. [Approach from a Perspective of Autoimmune Cerebellar Ataxia].
Yoshikura N; Kimura A; Takekoshi A; Shimohata T
Brain Nerve; 2020 Sep; 72(9):961-967. PubMed ID: 32934185
[TBL] [Abstract][Full Text] [Related]
19. Septin-3 autoimmunity in patients with paraneoplastic cerebellar ataxia.
Miske R; Scharf M; Borowski K; Rieckhoff N; Teegen B; Denno Y; Probst C; Guthke K; Didrihsone I; Wildemann B; Ruprecht K; Komorowski L; Jarius S
J Neuroinflammation; 2023 Mar; 20(1):88. PubMed ID: 36997937
[TBL] [Abstract][Full Text] [Related]
20. Rapidly progressing cerebellar ataxia associated with anti-GAD antibodies.
Quintas S; Ruiz RL; Zapata-Wainberg G; Vivancos J
Neurologia (Engl Ed); 2018 May; 33(4):273-275. PubMed ID: 27091680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
